ERBB2 and prostate carcinoma: LFK index was 1.93 (moderate publication bias risk, p = 0.054).<h4>Conclusions</h4>HER2 overexpression is rare in prostatic carcinomas but nearly half show HER2 expression of Score 1 or above.